Click here to view online. Add this email to your safelist.

AstraZeneca logo

Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups

31 August 2020

AZD1222 development expanded into a Phase III clinical trial in the US to assess its safety, efficacy and immunogenicity.

Read more  Read more

RSS Feed  RSS Feed Twitter  Follow us on Twitter LinkedIn  Follow us on LinkedIn
Legal notice and Terms of Use Privacy policy Cookie policy Site map © AstraZeneca 2020

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.